32.50.Z - Production of medical devices, instruments, and products, including dental products
62.01.Z - Activities related to programming, IT consulting, and related activities
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
66.30.Z - Activities related to fund management
68.10.Z - Real estate activities on own account and development of building projects
68.20.Z - Rental and management of own or leased real estate
68.32.Z - Other real estate activities on behalf of third parties
70.22.Z - Head office activities and management consultancy
72.11.Z - Scientific research and development activities
73.11.Z - Advertising agency activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,2 | -0,5 | -0,1 | 70,4 |
EBITDA | 0,4 | -0,1 | 0,8 | 845,9 |
Short time liabilities | 1,5 | 2 | 1,6 | -18,6 |
Equity capital | 0,9 | 0,5 | -0,5 | -207,4 |
Operating profit (EBIT) | 0,2 | -0,5 | 0,1 | 111,9 |
Assets | 3,2 | 3,1 | 2,4 | -20,2 |
Net profit (loss) | 0,2 | -0,5 | -0,1 | 70,4 |
Cash | 0 | 0 | 0 | 68,1 |
Liabilities and provisions for liabilities | 2,3 | 2,6 | 2,9 | 12,3 |
Net income from sale | 1,6 | 0,7 | 0,4 | -49,7 |
Working assets | 0,7 | 0,5 | 0,5 | -12,5 |
Depreciation | 0,2 | 0,4 | 0,8 | 109,6 |
% | % | % | p.p. | |
Profitability of capital | 19 | -103,8 | 28,7 | 132,5 |
Equity capital to total assets | 29 | 14,8 | -19,9 | -34,7 |
Gross profit margin | 10,8 | -66,5 | -39,3 | 27,2 |
EBITDA Margin | 24,6 | -15,4 | 227,9 | 243,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 332 | 1025 | 1661 | 636 |
Current financial liquidity indicator | 0.2979671061038971 | 0.19787320494651794 | 0.19070105254650116 | 0 |
Net dept to EBITDA | 2.0495805740356445 | -12.400382995605469 | 2.090517997741699 | 14,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane